Skip to content
healthcare.dev

Oxybutynin Chloride Extended Release

NDC 62175-270, Oxybutynin Chloride, tablet, extended release, from Lannett Company, Inc..

Product NDC
62175-270
Status
Listed
Labeler
Lannett Company, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078503
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62175-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
62175-270-3762175027037100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37)
62175-270-4162175027041500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5950dba-d92b-46a0-993f-af9f9ddb52bf
  • NADAC price for package 62175027037

    GET /v1/drugs/nadac/62175027037
  • NADAC price for package 62175027041

    GET /v1/drugs/nadac/62175027041

Use it

Look up 62175-270 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62175-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62175-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.